glp-1 cardiovascular outcomes 2025 news Agonists in Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Cardiovascular Effects and Tolerability of
Description
No studies have been conducted on oral semaglutide alternatives like Rybelsus or the Wegovy pill, but because pill versions contain an absorption enhancer to help the drug get through the stomach lining, semaglutide may be more likely to pass through to breast milk
l e Roux Researchers obtained data from 262 adults who began using liraglutide or semaglutide from January 2023 to March 2024 and had at least two follow-up visits after GLP-1 initiation (mean age, 46 years
This lipid-modifying potential is not confined to diabetic patients alone
How do GLP-1 Medications Promote Weight Loss
